Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 174

1.

Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.

Cerasuolo A, Annunziata C, Tortora M, Starita N, Stellato G, Greggi S, Maglione MG, Ionna F, Losito S, Botti G, Buonaguro L, Buonaguro FM, Tornesello ML.

Oncotarget. 2017 Mar 7. doi: 10.18632/oncotarget.15977. [Epub ahead of print]

2.

An Engineered Cell-Instructive Stroma for the Fabrication of a Novel Full Thickness Human Cervix Equivalent In Vitro.

De Gregorio V, Imparato G, Urciuolo F, Tornesello ML, Annunziata C, Buonaguro FM, Netti PA.

Adv Healthc Mater. 2017 Mar 29. doi: 10.1002/adhm.201601199. [Epub ahead of print]

PMID:
28371541
3.

An overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases.

Tornesello AL, Tornesello ML, Buonaguro FM.

Mini Rev Med Chem. 2017 Jan 20. [Epub ahead of print]

PMID:
28117023
4.

MDM2 gene polymorphisms and risk of classic Kaposi's sarcoma among Iranian patients.

Varmazyar S, Marashi SM, Shoja Z, Tornesello ML, Buonaguro FM, Shahmahmoodi S, Safaie-Naraghi Z, Jalilvand S.

Med Microbiol Immunol. 2017 Apr;206(2):157-163. doi: 10.1007/s00430-016-0491-9. Epub 2017 Jan 12.

PMID:
28083704
5.

Immunological effects of a novel RNA-based adjuvant in liver cancer patients.

Circelli L, Petrizzo A, Tagliamonte M, Heidenreich R, Tornesello ML, Buonaguro FM, Buonaguro L.

Cancer Immunol Immunother. 2017 Jan;66(1):103-112. doi: 10.1007/s00262-016-1923-5. Epub 2016 Nov 10.

PMID:
27832318
6.

HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.

De Re V, De Zorzi M, Caggiari L, Lauletta G, Tornesello ML, Fognani E, Miorin M, Racanelli V, Quartuccio L, Gragnani L, Russi S, Pavone F, Ghersetti M, Costa EG, Casarin P, Bomben R, Mazzaro C, Basaglia G, Berretta M, Vaccher E, Izzo F, Buonaguro FM, De Vita S, Zignego AL, De Paoli P, Dolcetti R.

Oncotarget. 2016 Jun 21;7(25):37487-37497. doi: 10.18632/oncotarget.9303.

7.

Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery.

Petrizzo A, Caruso FP, Tagliamonte M, Tornesello ML, Ceccarelli M, Costa V, Aprile M, Esposito R, Ciliberto G, Buonaguro FM, Buonaguro L.

Sci Rep. 2016 Jul 8;6:29258. doi: 10.1038/srep29258.

8.

Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma.

Pezzuto F, Izzo F, Buonaguro L, Annunziata C, Tatangelo F, Botti G, Buonaguro FM, Tornesello ML.

Oncotarget. 2016 Aug 23;7(34):54253-54262. doi: 10.18632/oncotarget.9801.

9.

Solid Phase Formylation of N-Terminus Peptides.

Tornesello AL, Sanseverino M, Buonaguro FM.

Molecules. 2016 Jun 4;21(6). pii: E736. doi: 10.3390/molecules21060736.

10.

Detection of human papillomavirus DNA in peri-tumor tissues and pelvic lymph nodes as potential molecular marker of micrometastasis in cervical cancer.

Tortora M, Annunziata C, Liguori G, Losito S, Botti G, Greggi S, Buonaguro L, Buonaguro FM, Tornesello ML.

Infect Agent Cancer. 2016 May 11;11:22. doi: 10.1186/s13027-016-0068-7. eCollection 2016.

11.

Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation.

Zanotta N, Tornesello ML, Annunziata C, Stellato G, Buonaguro FM, Comar M.

PLoS One. 2016 Mar 18;11(3):e0151851. doi: 10.1371/journal.pone.0151851. eCollection 2016.

12.

Cancer vaccines for hepatocellular carcinoma: future directions.

Buonaguro FM, Buonaguro L.

Immunotherapy. 2016;8(4):391-3. doi: 10.2217/imt-2015-0018. No abstract available.

PMID:
26973120
13.

Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.

Tornesello ML, Buonaguro L, Izzo F, Buonaguro FM.

Oncotarget. 2016 May 3;7(18):25087-102. doi: 10.18632/oncotarget.7837.

14.

A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice.

Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Rea D, Barbieri A, Arra C, Maiolino P, Tornesello M, Ciliberto G, Buonaguro FM, Buonaguro L.

J Transl Med. 2016 Feb 24;14:58. doi: 10.1186/s12967-016-0812-1.

15.

Infectious Agents and Cancer reviewer acknowledgement 2015.

Buonaguro FM, Mbulaiteye SM, Tornesello ML.

Infect Agent Cancer. 2016 Feb 10;11:10. doi: 10.1186/s13027-016-0055-z. eCollection 2016.

16.

Combinatorial immunotherapy strategies for hepatocellular carcinoma.

Tagliamonte M, Petrizzo A, Tornesello ML, Ciliberto G, Buonaguro FM, Buonaguro L.

Curr Opin Immunol. 2016 Apr;39:103-13. doi: 10.1016/j.coi.2016.01.005. Epub 2016 Feb 4. Review.

PMID:
26851637
17.

Cancer Diagnostic and Predictive Biomarkers 2015.

Buonaguro FM, Pauza CD, Tornesello ML, Hainaut P, Franco R.

Biomed Res Int. 2015;2015:235985. doi: 10.1155/2015/235985. Epub 2015 Oct 12. No abstract available.

18.

Identification of Human Herpesvirus 8 Sequences in Conjunctiva Intraepithelial Neoplasia and Squamous Cell Carcinoma of Ugandan Patients.

Starita N, Annunziata C, Waddell KM, Buonaguro L, Buonaguro FM, Tornesello ML.

Biomed Res Int. 2015;2015:801353. doi: 10.1155/2015/801353. Epub 2015 Oct 5. Review.

19.

Functional characterization of biodegradable nanoparticles as antigen delivery system.

Petrizzo A, Conte C, Tagliamonte M, Napolitano M, Bifulco K, Carriero V, De Stradis A, Tornesello ML, Buonaguro FM, Quaglia F, Buonaguro L.

J Exp Clin Cancer Res. 2015 Oct 6;34:114. doi: 10.1186/s13046-015-0231-9.

20.

Systems Biology Approach for Cancer Vaccine Development and Evaluation.

Circelli L, Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L.

Vaccines (Basel). 2015 Jul 14;3(3):544-55. doi: 10.3390/vaccines3030544. Review.

Supplemental Content

Loading ...
Support Center